Spotex
Product Images NDC 82160-126

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Spotex (NDC 82160-126). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pella Pharmaceuticals Co. Ltd, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Primary Package (Primary Package.)

Spotex Erythromycin 4% gel 30g tube label showing product name and strength on a blue patterned background, with details including the active ingredient erythromycin content, manufacturer Pella Pharmaceuticals Co. Ltd Jordan, and storage instructions. The label uses colors Pantone 2613, 2593, 3105, and black.*

FDA Label Image

Secondary Package (Secondary Package.)

Packaging label for Spotex gel, showing a flat, unfolded box design. The label includes the brand name Spotex prominently in black text on a light blue background with decorative patterns. It indicates a 30g gel with 4% erythromycin. The labeler is Pella Pharmaceuticals Co. Ltd, with website www.dermapharma.com.jo. Additional details include storage instructions and a barcode at the bottom. Purple and black color accents highlight specific text such as 'RX ONLY' and product strength.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.